These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 24324048
21. Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage. Laurent S. J Hypertens Suppl; 2003 Jun; 21(3):S11-8. PubMed ID: 12929470 [Abstract] [Full Text] [Related]
26. Implications of the ADVANCE study for clinical practice. Zannad F. J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850 [Abstract] [Full Text] [Related]
27. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine. Mourad JJ, Le Jeune S, Pirollo A, Mourad C, Gaudouen Y, Lopez-Sublet M. Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889 [Abstract] [Full Text] [Related]
30. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, Cass A, Cooper M, Grobbee D, Hamet P, Harrap S, Liu L, Mancia G, Mogensen CE, Poulter N, Rodgers A, Williams B, MacMahon S, Chalmers J, ADVANCE Collaborative Group. J Hypertens; 2010 Jun; 28(6):1141-9. PubMed ID: 20486273 [Abstract] [Full Text] [Related]
31. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. de Luca N, Mallion JM, O'Rourke MF, O'Brien E, Rahn KH, Trimarco B, Romero R, De Leeuw PW, Hitzenberger G, Battegay E, Duprez D, Sever P, Safar ME. Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062 [Abstract] [Full Text] [Related]
32. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension. Kang S, Wu YF, An N, Ren M. Clin Ther; 2004 Feb; 26(2):257-70. PubMed ID: 15038948 [Abstract] [Full Text] [Related]
33. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence. Chalmers J, Joshi R, Kengne AP, Ninomiya T, Bi Y, Bompoint S, Billot L, Patel A, ADVANCE Collaborative Group. J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849 [Abstract] [Full Text] [Related]
35. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M, Hamet P, Heller SR, Lisheng L, MacMahon S, Mancia G, Neal B, Pan CY, Patel A, Poulter N, Travert F, Woodward M, ADVANCE Collaborative group. Diabetologia; 2009 Nov; 52(11):2328-2336. PubMed ID: 19688336 [Abstract] [Full Text] [Related]
36. Efficacy of a very-low-dose combination of perindopril and indapamide--preterax compared with cilazapril monotherapy in patients with inadequate blood pressure control--a randomized, double-blind, add-on study. Sung SH, Wu TC, Lin SJ, Chen JW. J Chin Med Assoc; 2008 May; 71(5):247-53. PubMed ID: 18490229 [Abstract] [Full Text] [Related]
40. Protection of patients with diabetes, with or without hypertension: implications of ADVANCE for clinical practice. Mancia G, Grassi G. J Hypertens Suppl; 2009 May; 27(1):S19-23. PubMed ID: 19483504 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]